Join the PharmaShots Family of 20000+ Subscribers by PharmaShots

PharmaShots Nov 6, 2025

AmacaThera Inks a ~$230M Exclusive Global Licensing Deal with Pacira BioSciences to Advance AMT-143

Shots: Ref: PRNewsWire| Image: AmacaThera & Pacira | Press Release Related News:- Ailux Collaborates with Eli Lilly to…

Read article →
PharmaShots Nov 6, 2025

Neurona Therapeutics’ NRTX-1001 Secures the EMA’s Priority Medicines (PRIME) Designation for Drug-Resistant Focal Epilepsy

Shots: Ref: Neurona Therapeutics| Image: Neurona Therapeutics| Press Release Related News:- Meitheal Pharmaceuticals…

Read article →
PharmaShots Nov 6, 2025

Averoa Receives the MHRA’s Approval for Xoanacyl to Treat Chronic Kidney Disease (CKD)

Shots: Ref: Averoa | Image: Averoa | Press Release Related News:- Averoa Receives the EC’s Approval for Xoanacyl to…

Read article →
PharmaShots Nov 6, 2025

Ailux Collaborates with Eli Lilly to Accelerate Bispecific Antibody Development

Shots: Ref: Ailux | Image: Ailux & Eli Lilly | Press Release Related News:- Merck Signs an R&D Funding Deal with…

Read article →
PharmaShots Nov 5, 2025

Know Your Investor: Samsara Biocapital (November’25 Edition)  

Shots: Welcome to the November edition of Know Your Investor, highlighting visionary investors driving healthcare and…

Read article →
PharmaShots Nov 5, 2025

QIAGEN to Acquire Parse Biosciences for ~$280M

Shots: Ref: QIAGEN | Image: Parse Biosciences | Press Release Related News:- Metsera Declares Novo Nordisk’s ~$9B…

Read article →
PharmaShots Nov 5, 2025

Merck Signs an R&D Funding Deal with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)

Shots: Ref: Merck | Image: Merck & Blackstone Life Sciences | Press Release Related News:- Boehringer Ingelheim and…

Read article →
PharmaShots Oct 29, 2025

Disease of the Month – Paroxysmal nocturnal hemoglobinuria (PNH) 

Shots: For a detailed landscape analysis and customized insights on PNH, contact our team at [email protected]…

Read article →